CLDX · Forms 3, 4, 5
Insider trades at Celldex Therapeutics, Inc.
No open-market insider buys or sells at Celldex Therapeutics, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Celldex Therapeutics, Inc. (CLDX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Celldex Therapeutics, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Teri L Lawver | SVP & Chief Commercial Officer | Options or other derivatives | Form 4 | ||||
| Freddy A. Jimenez | SVP & GENERAL COUNSEL | Options or other derivatives | Form 4 | ||||
| Diane C. Young | SVP, CHIEF MEDICAL OFFICER | Options or other derivatives | Form 4 | ||||
| Margo Heath-Chiozzi | SVP OF REGULATORY AFFAIRS | Options or other derivatives | Form 4 | ||||
| Samuel Bates Martin | SVP AND CFO | Options or other derivatives | Form 4 | ||||
| Sarah Cavanaugh | SVP OF CORP AFFAIRS & ADMIN. | Options or other derivatives | Form 4 | ||||
| Elizabeth Crowley | SR. VP & CPDO | Options or other derivatives | Form 4 | ||||
| Ronald Pepin | SR. VP & CBO | Options or other derivatives | Form 4 | ||||
| Tibor Keler | EXECUTIVE VP & CSO | Options or other derivatives | Form 4 | ||||
| Anthony S Marucci | PRESIDENT & CEO | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.